THE PROBLEM OF THE OPTIMAL PHARMACOTHERAPY CHOICE IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE

QR Code

THE PROBLEM OF THE OPTIMAL PHARMACOTHERAPY CHOICE IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE

The problem of the "optimal pharmacotherapy" choice in patients with stable coronary artery disease is discussed. Expert’s opinions are presented concerning first-line antiischemic drugs and about current approaches to the choosing additional (adjuvant) antiischemic drugs. The practical ap...

Full description

Saved in:

Bibliographic Details
Main Authors:	S. R. Gilyarevskiy, V. A. Orlov, I. M. Kuz'mina
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-12-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	optimal pharmacotherapy coronary heart disease
Online Access:	https://www.rpcardio.online/jour/article/view/470
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Multivariable Analysis of Primary Care Physician Adherence to Guideline-recommended Pharmacotherapy of Stable Coronary Artery Disease
by: S. K. Zyryanov, et al.
Published: (2021-03-01)

Comparative analysis of pharmacotherapy for patients with coronary artery disease and type 2 diabetes at various healthcare stages
by: M. A. Kokozheva, et al.
Published: (2024-04-01)

The Role of Adherence to Basic Pharmacotherapy of Heart Failure for Prevention of Late Adverse Events in Patients with Coronary Artery Disease and Left Ventricular Dysfunction After Surgical Revascularization of Myocardium
by: O. A. Yepanchintseva, et al.
Published: (2020-11-01)

Zofenopril in the treatment of patients with arterial hypertension and stable coronary heart disease: effects on oxidative stress and flowdependent vasodilatation
by: F. T. Ageev, et al.
Published: (2011-06-01)

The impact of polypharmacy on adherence to pharmacotherapy for coronary heart disease with comorbid conditions: insights from the EUROASPIRE V observational study in Ukraine
by: M. M. Dolzhenko, et al.
Published: (2025-06-01)

Therapeutic surveillance and the optimization of pharmacotherapy
by: Maria Crivineanu
Published: (2008-06-01)

Analysis of the characteristics of pharmacotherapy for outpatients with cardiovascular diseases in the Russian Federation based on the results of an online survey of doctors
by: N. O. Kryukova, et al.
Published: (2024-01-01)

Treatment Adherence to Drug Therapyin Patients with Stable Coronary Artery Disease During the COVID-19 Pandemic
by: S. Y. Martsevich, et al.
Published: (2021-03-01)

Overview of imaging methods used in the diagnosis of stable coronary artery disease
by: I. V. Tarasova, et al.
Published: (2023-06-01)

PHARMACOTHERAPY OF ARTERIAL HYPERTENSION IN ELDERLY PATIENTS: FOCUS ON OCTOGENARIANS
by: E. A. Ushkalova, et al.
Published: (2016-05-01)

Elements of artificial intelligence in a predictive personalized model of pharmacotherapy choice in patients with heart failure with mildly reduced ejection fraction of ischemic origin
by: O. A. Osipova, et al.
Published: (2023-09-01)

ANALYSIS OF COST STRUCTURE FOR PHARMACOTHERAPY OF PATIENTS WITH STABLE ANGINA (THE CASE OF CARDIOLOGY DEPARTMENT OF TVER REGIONAL CLINICAL HOSPITAL)
by: M. A. Demidova, et al.
Published: (2015-12-01)

LIFE QUALITY ASSESSMENT OF PATIENTS WITH STABLE CORONARY ARTERY DISEASE AFTER MYOCARDIAL REVASCULARIZATION
by: I. A. Narkevich, et al.
Published: (2021-05-01)

Causes of paroxysmal dyspnea in patients with stable coronary artery disease
by: S. F. Yarmedova, et al.
Published: (2024-06-01)

ABOUT SOME MISTAKES AND REASONS FOR THEM IN ACUTE CORONARY SYNDROME TREATMENT
by: G. I. Zimarin, et al.
Published: (2015-12-01)

ALTERNATIVE APPROACHES TO THE USE OF TWO COMPONENT ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME: EVIDENCES, RECOMMENDATIONS AND REAL PRACTICE
by: S. R. Gilyarevskiy, et al.
Published: (2015-12-01)

Use of pharmacoinvasive approach to the treatment of patients with ST segment elevation acute coronary syndrome: state of the problem
by: S. R. Gilyarevskiy, et al.
Published: (2015-12-01)

Personalized trimetazidine prescription as a cytoprotective agent in patients with coronary artery disease
by: O. V. Romashchenko
Published: (2021-07-01)

Pharmacotherapy algorithm for post-traumatic stress disorder
by: A. V. Vasileva, et al.
Published: (2023-10-01)

Secondary Prevention and Quality of Life of Patients with Stable Coronary Heart Disease
by: E. D. Zharkova, et al.
Published: (2023-05-01)

THE STRUCTURE OF DRUG PRESCRIPTION IN ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION ON THE FIRST DAY OF HOSPITAL THERAPY
by: O. V. Reshetko, et al.
Published: (2016-01-01)

THE RESULTS OF A SURVEY OF SURGEONS ON THE SAFETY OF PHARMACOTHERAPY
by: I. N. Ochakovskaya, et al.
Published: (2018-12-01)

APPLICATION OF PHARMACOTHERAPY PRINCIPLES IN CHRONIC KIDNEY DISEASE PATIENTS
by: Juniarto Mende, et al.
Published: (2025-08-01)

2020 Clinical practice guidelines for Stable coronary artery disease
by: . Russian Society of Cardiology (RSC)
Published: (2020-12-01)

Hyperhomocysteinemia and lipid peroxidation in stable coronary heart disease
by: O. L. Belaya, et al.
Published: (2007-02-01)

Pharmacotherapy of insomnia in childhood
by: Z. G. Tadtaeva, et al.
Published: (2022-07-01)

Trimetazidine MR effects on heart remodeling in stable coronary heart disease patients
by: E. M. Khurs, et al.
Published: (2007-02-01)

Gout, hyperuricemy and cardiovascular diseases. Approaches to pharmacotherapy
by: V. V. Tsurko, et al.
Published: (2021-06-01)

Pharmacotherapy for lumbago
by: A.E. Karateev
Published: (2014-05-01)

Assessment of the Quality of Drug Therapy in Patients with Stable Coronary Artery Disease in the Second Stage of the ALIGN Study
by: E. D. Zharkova, et al.
Published: (2022-07-01)

Optimization of a Comprehensive Prehabilitation Program for Patients with Stable Coronary Artery Disease Undergoing Elective Coronary Artery Bypass Grafting
by: Yu. A. Argunova, et al.
Published: (2020-09-01)

The quality of received drug therapy in patients with stable coronary heart disease according to the ALIGN (TherApy in stabLe Coronary Artery dIsease Patients According to Clinical GuideliNes) study
by: E. D. Zharkova, et al.
Published: (2022-10-01)

THE PREVALENCE OF INTACT CORONARY ARTERIES IN RELATION WITH INDICATIONS FOR SCHEDULED CORONARY ARTERIOGRAPHY
by: E. V. Korok, et al.
Published: (2016-02-01)

Eurasian Guidelines for the diagnostics and management of stable coronary artery disease (2020-2021)
by: Yu. A. Karpov, et al.
Published: (2021-09-01)

INFLUENCE OF HEALTH SCHOOL TRAINING OF PATIENTS WITH ISCHEMIC HEART DISEASE ON PHARMACOTHERAPY PROFILE AND COST (АВС/VEN ANALYSIS)
by: A. V. Kontsevaja, et al.
Published: (2016-01-01)

Stable coronary heart disease treatment: focus on beta-adrenoblockers
by: V. I. Makolkin
Published: (2008-12-01)

MicroRNA level in patients with stable coronary artery disease with borderline coronary artery stenosis
by: D. A. Yakhontov, et al.
Published: (2022-11-01)

EVALUATION OF THE PREVALENCE OF CARDIOVASCULAR EVENTS AND MORTALITY IN STABLE CORONARY HEART DISEASE PATIENTS DEPENDING ON BASELINE CORONARY COLLATERAL BLOOD FLOW (FIVE YEAR FOLLOW-UP)
by: E. V. Kozlova, et al.
Published: (2018-04-01)

Immediate and Long-term Results of Stenting of the Unprotected Left Coronary Artery Trunk in Patients with Stable Coronary Heart Disease
by: G. K. Arutyunyan, et al.
Published: (2019-05-01)

Modern achievements in pharmacotherapy of osteoarthritis based on endo- and phenotyping
by: I. V. Sarvilina, et al.
Published: (2021-10-01)